Skip to content

Efficacy and Safety of StENt-assisted treatment for CErebral aneurysms

Efficacy and Safety of StENt-assisted treatment for CErebral aneurysms - ESSENCE

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000009179
Enrollment
1000
Registered
2012-10-24
Start date
2012-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial aneurysm

Interventions

None listed

Sponsors

Translational Research Informatics, Foundation for Biomedical Research and Innovation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. stent assisted embolization of intracranial aneurysm 2. 20 or more years old

Exclusion criteria

Exclusion criteria: not decided

Design outcomes

Primary

MeasureTime frame
death, stroke and hemorrhagic event within 2-years after treatment

Secondary

MeasureTime frame
1. death, stroke, hemorrhagic event within 30days or between 31days to 2years after treatment 2. any change of anti-thrombotic therapy within 2years after treatment 3. recanalization or re-treatment within 2years after treatment 4. stent stenosis or occlusion within 2years after treatment 5. any adverse event within 2years after treatment

Countries

Japan

Contacts

Public ContactNobuyuki Sakai

Kobe City Medical Center general Hospital Neurosurgery

078-302-4321

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026